In vitro diagno substances, reagents
Ended Awarded
- Contract number
- HHSN26300233
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,419
Award facts
- Contract value 100% obligated
- $6,419.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC received a $6,419.20 firm fixed price Blanket Purchase Agreement (BPA) call for in vitro diagnostic substances and reagents, awarded by the Office of the Director on December 1, 2009, with a completion date of December 31, 2009. The contract was performed in Valencia, California and was not designated as a set-aside award. As a subsidiary of Netherlands-based Qiagen N.V., Qiagen, LLC specializes in molecular diagnostics and scientific equipment, providing advanced reagents and consumables to federal agencies across multiple sectors including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense.
This BPA call represents a task order under a larger blanket purchase agreement vehicle, enabling efficient procurement of specialized diagnostic reagents and related products as needed by the government agency. Qiagen's federal contract portfolio demonstrates consistent capability in delivering molecular diagnostics solutions, including tuberculosis testing reagents such as QuantiFERON TB Gold Plus, DNA/RNA extraction kits, and associated laboratory consumables. The BPA structure allows the government to place orders for required diagnostic substances and reagents on an as-needed basis, streamlining procurement for recurring requirements while maintaining firm fixed pricing.
Quick answers
Who was awarded contract HHSN26300233?
HHSN26300233 was awarded to Qiagen, LLC by Office of the Director (National Institutes of Health) on December 1, 2009.
How much is contract HHSN26300233 worth?
The government has obligated $6,419 on HHSN26300233.
Is contract HHSN26300233 an order under another contract?
Yes. HHSN26300233 is a BPA call under HHSN263200100054095B, a blanket purchase agreement.
Was contract HHSN26300233 competed?
The extent of competition for HHSN26300233 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award